Summit Biosciences Announces FDA Approval of ANDA for Sumatriptan Nasal Spray USP, 5 mg and 20 mg 

Summit Biosciences is a specialty pharmaceutical company focused on developing, manufacturing and commercializing generic and innovative nasal spray drug products. In addition to developing our own products, we provide contract development and manufacturing services to our partners and to our clients for a wide variety of nasally delivered drug products and delivery systems.

Our FDA approved and DEA registered facility and operations are compliant with FDA cGMPs and are capable of supporting any stage of product development, from conceptual to commercial.

Summit Biosciences Inc.    I   UK Coldstream Research Campus
1513 Bull Lea Rd, Lexington, KY 40511   I   P: 859-254-0180